SCHEMBL7664372

SCHEMBL7664372

CCCc1cnc(-c2ccc(Cl)cc2Oc2ccccc2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ GRM5 P41594 1/20 0.39
▸ PPARG P37231 3/20 0.37
▸ PPARD Q03181 3/20 0.37
▸ PPARA Q07869 3/20 0.37
▸ GAA P10253 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670839 0.85 CYP11B1 (0.41) MAPTSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL7664751 0.85 HTR2A (0.40) GRM5L3MBTL1
SCHEMBL7672934 0.82 TTR (0.34) MAPTLMNAGAANPSR1MEN1
SCHEMBL7664382 0.81 SLC6A2 (0.43) MAPTLMNANPSR1NPC1RAB9A
SCHEMBL7664066 0.76 BCL2L2 (0.37) MAPTNPSR1HTTL3MBTL1
SCHEMBL7666933 0.76 CYP11B1 (0.42) SMN1; SMN2LMNACYP1A2CYP3A4CYP2C19
SCHEMBL7666947 0.74 FEN1 (0.38) MAPTNPSR1MEN1KMT2AHTT
SCHEMBL7667019 0.70 TRPA1 (0.41) ALDH1A1HTTL3MBTL1
SCHEMBL14871868 0.68 CYP1A2 (0.56) MAPTSMN1; SMN2LMNACYP1A2CYP3A4
SCHEMBL7664578 0.68 GRM5 (0.38) MAPTSMN1; SMN2LMNAGRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback